Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03411109 · ClinicalTrials.gov registry record
Outcomes of Intrathecal Analgesia in Colorectal Surgery
A clinical trial of Surgery, sponsored by Mayo Clinic.
- Completed
- Registry status
- 601
- Enrollment target
- 2
- Study locations
NCT03411109: Completed study of Surgery, sponsored by Mayo Clinic.
NCT03411109 is a study of Surgery that has completed, run by Mayo Clinic. The registered enrollment target is 601 participants, below the 52,847-participant average among 120 other Surgery trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03411109, a study of Surgery, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 601 participants
- Enrollment target
- 2
- Study locations
Study Summary
Multimodal analgesia, sometimes including intrathecal analgesia (IA), is essential in any enhanced recovery pathway (ERP). This study aimed to evaluate the safety, feasibility, and optimal IA regimen in colorectal surgical patients.
Primary Outcome
Time to return of bowel function is defined by the presence of flatus and a bowel movement
Conditions Studied
Interventions
- DRUG Hydromorphone Hydrochloride
Study Locations (2)
Florida
- Mayo Clinic - Jacksonville
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 601 participants |
| Start Date | 2012-10-01 |
| Est. Completion | 2013-12-31 |
What the finished NCT03411109 record still lists
NCT03411109 is an observational study that tracks outcomes without assigning an intervention. The registered 601 participants enrollment target is mid-sized for trials with a published cap, below the 52,847-participant average among 120 other Surgery trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Surgery appearing as the primary indexed condition, and to 1 intervention - of which Hydromorphone Hydrochloride is the first listed.
NCT03411109 reports a single indexed study location in Florida, Minnesota.
Frequently Asked Questions
What is clinical trial NCT03411109 about?
NCT03411109 is a clinical study titled "Outcomes of Intrathecal Analgesia in Colorectal Surgery". Multimodal analgesia, sometimes including intrathecal analgesia (IA), is essential in any enhanced recovery pathway (ERP). This study aimed to evaluate the safety, feasibility, and optimal IA regimen in colorectal surgical patients.
What is the current status of trial NCT03411109?
This trial is currently completed. The enrollment target is 601 participants. The study started on 2012-10-01. Estimated completion is 2013-12-31.
What conditions does trial NCT03411109 study?
This clinical trial studies the following conditions: Surgery.
What interventions are being tested in trial NCT03411109?
The interventions under investigation include: Hydromorphone Hydrochloride (DRUG).
Who is sponsoring clinical trial NCT03411109?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03411109 being conducted?
This trial has 2 study locations across Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03411109's enrollment target sits among peer trials
601 20th of 120 higher than 101 of 120 other Surgery trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Surgery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Terumo Aortic Global Endovascular Registry
RECRUITING
-
A Study of the Use of 3D Technology to Guide Head and Neck Surgery
RECRUITING · NA
-
Comparing Analgesic Regimen Effectiveness and Safety for Surgery (CARES) Trial
RECRUITING · Phase 4
-
NO During CPB in Neonates to Reduce Risk of AKI
RECRUITING · Phase 3
-
INCLUDE Program: A Perioperative Wellness Program Tailored for Black Surgical Patients
RECRUITING · NA
-
Ultrasound Evaluation for Improving Patient Selection in vNOTES
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI